ArticlePharmaceutical biology2024

Shenqi Fuzheng injection restores the sensitivity to gefitinib in non-small cell lung cancer by inhibiting the IL-22/STAT3/AKT pathway.

Jiali Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.